Citigroup’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.28M | Sell |
220,452
-85,723
| -28% | -$2.1M | ﹤0.01% | 1929 |
|
|
2025
Q4 | $6.93M | Buy |
306,175
+194,117
| +173% | +$4.22M | ﹤0.01% | 1789 |
|
|
2025
Q3 | $2.26M | Sell |
112,058
-344,563
| -75% | -$5.77M | ﹤0.01% | 2574 |
|
|
2025
Q2 | $6.52M | Buy |
456,621
+257,560
| +129% | +$3.01M | ﹤0.01% | 1687 |
|
|
2025
Q1 | $2.09M | Sell |
199,061
-85,055
| -30% | -$962K | ﹤0.01% | 2665 |
|
|
2024
Q4 | $3.44M | Buy |
284,116
+48,074
| +20% | +$629K | ﹤0.01% | 2328 |
|
|
2024
Q3 | $3.47M | Sell |
236,042
-334,081
| -59% | -$4.65M | ﹤0.01% | 2163 |
|
|
2024
Q2 | $8.23M | Buy |
570,123
+424,744
| +292% | +$6.79M | 0.01% | 1356 |
|
|
2024
Q1 | $2.37M | Buy |
145,379
+21,931
| +18% | +$343K | ﹤0.01% | 2305 |
|
|
2023
Q4 | $1.84M | Buy |
123,448
+31,228
| +34% | +$354K | ﹤0.01% | 2309 |
|
|
2023
Q3 | $1.04M | Sell |
92,220
-132,612
| -59% | -$1.54M | ﹤0.01% | 2479 |
|
|
2023
Q2 | $2.26M | Sell |
224,832
-317,886
| -59% | -$2.95M | ﹤0.01% | 2086 |
|
|
2023
Q1 | $5.1M | Buy |
542,718
+322,953
| +147% | +$3.81M | ﹤0.01% | 1498 |
|
|
2022
Q4 | $2.69M | Sell |
219,765
-214,021
| -49% | -$2.67M | ﹤0.01% | 1828 |
|
|
2022
Q3 | $5.38M | Sell |
433,786
-38,218
| -8% | -$668K | ﹤0.01% | 1517 |
|
|
2022
Q2 | $9.27M | Sell |
472,004
-1,451,750
| -75% | -$34.4M | 0.01% | 1192 |
|
|
2022
Q1 | $50.2M | Buy |
1,923,754
+320,895
| +20% | +$8.55M | 0.03% | 500 |
|
|
2021
Q4 | $45.5M | Buy |
1,602,859
+84,485
| +6% | +$2.63M | 0.02% | 597 |
|
|
2021
Q3 | $48.4M | Buy |
1,518,374
+225,142
| +17% | +$7.55M | 0.03% | 548 |
|
|
2021
Q2 | $44.9M | Buy |
1,293,232
+56,071
| +5% | +$1.85M | 0.03% | 570 |
|
|
2021
Q1 | $36.4M | Buy |
1,237,161
+411,158
| +50% | +$12.6M | 0.02% | 643 |
|
|
2020
Q4 | $25.3M | Buy |
826,003
+445,990
| +117% | +$13.6M | 0.02% | 889 |
|
|
2020
Q3 | $10.6M | Buy |
380,013
+253,144
| +200% | +$6.42M | 0.01% | 1331 |
|
|
2020
Q2 | $2.72M | Sell |
126,869
-14,911
| -11% | -$329K | ﹤0.01% | 2449 |
|
|
2020
Q1 | $3.17M | Buy |
141,780
+20,853
| +17% | +$571K | ﹤0.01% | 2061 |
|
|
2019
Q4 | $3.56M | Buy |
120,927
+16,835
| +16% | +$457K | ﹤0.01% | 2343 |
|
|
2019
Q3 | $2.77M | Sell |
104,092
-3,687
| -3% | -$111K | ﹤0.01% | 2509 |
|
|
2019
Q2 | $3.64M | Sell |
107,779
-1,472,400
| -93% | -$47.8M | ﹤0.01% | 2241 |
|
|
2019
Q1 | $50.7M | Buy |
1,580,179
+1,574,790
| +29,222% | +$48.5M | 0.05% | 395 |
|
|
2018
Q4 | $169K | Buy |
5,389
+1,187
| +28% | +$38.9K | ﹤0.01% | 5188 |
|
|
2018
Q3 | $147K | Buy |
+4,202
| New | +$148K | ﹤0.01% | 5536 |
|
Other funds holding ELAN
VPM
VCM
Citigroup's ELAN Position: Q1 2026 in Review
Citigroup reduced its Elanco Animal Health (ELAN) stake by 28% in Q1 2026, selling an estimated $2.1M and leaving 220,452 shares worth $5.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1929.
Citigroup first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $50.7M in Q1 2019. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.
- Citigroup held 220,452 shares of Elanco Animal Health worth $5.28M as of Q1 2026.
- Citigroup sold 85,723 Elanco Animal Health shares in Q1 2026, an estimated $2.1M.
- Elanco Animal Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #1929 holding.
- Citigroup first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
- Citigroup's Elanco Animal Health position peaked at $50.7M in Q1 2019.
- 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.